Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMOTE prasugrel single antiplatelet strategy study
NL-OMON60168Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of prasugrel in acute coronary syndrome (ACS) and Chronic Coronary Syndrome (CCS) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Net Adverse Clinical Events. Started Nov 2025; status: active, not recruiting.
02
Drugs
prasugrel
03
Conditions
acute coronary syndrome (ACS)Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on NL-OMON60168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60168.